Join
Live feed
·
INSIDERFilingvia Quantisnow
TCR2 Therapeutics Inc. logo

SEC Form 4: Menzel Garry E converted options into 221,058 shares and sold $11,687 worth of shares (8,408 units at $1.39) as part of a pre-agreed trading plan (tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TCRR (TCR2 Therapeutics Inc.) and more on Quantisnow.